Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.5 CAD | +1.29% | -6.14% | +5.97% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.97% | 40Cr | |
+13.67% | 7.9TCr | |
+13.06% | 888.77Cr | |
-22.91% | 436.1Cr | |
+33.84% | 429.43Cr | |
+10.76% | 409.66Cr | |
+6.75% | 215.95Cr | |
-30.28% | 212.93Cr | |
+8.58% | 200.59Cr | |
-44.99% | 175Cr |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics in Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree in Canada